Table 5.
Characteristics stratified by histopathologic class: Treatment
| Treatment | Focal (n=14) | Crescentic (n=65) | Mixed (n=23) | Sclerotic (n=8) | P Value |
|---|---|---|---|---|---|
| Intensive treatmenta | 8 (57) | 33 (51) | 16 (70) | 4 (50) | 0.46 |
| Plasma exchange | 12 (86) | 53 (82) | 21 (91) | 5 (63) | 0.32 |
| Cyclophosphamide | 13 (93) | 46 (71) | 23 (100) | 6 (75) | <0.01 |
| Corticosteroids | 14 (100) | 62 (95) | 23 (100) | 7 (88) | 0.33 |
| Azathioprine | 4 (29) | 8 (12) | 6 (26) | 3 (38) | 0.11 |
| Mycophenolate mofetil | 2 (14) | 7 (11) | 2 (9) | 1 (13) | 0.92 |
| Rituximab | 3 (21) | 3 (5) | 4 (17) | 0 (0) | 0.06 |
Data are number (%), mean±SD, or median (interquartile range). Total, n=110 patients.
a
Intensive treatment was defined as treatment consisting of at least seven plasma exchanges, corticosteroids, and cyclophosphamide, mycophenolate mofetil or rituximab.